We Are LC Sciences
- Headquarters in Houston, Texas – USA
- Offices in USA & China
- Representatives in Europe, Japan, Korea, & India
- Customers in > 40 countries
- First microRNA microarray service provider (since 2005)
- Leading position in customer publications in peer reviewed journals
What We Do
While some recent breakthrough discoveries have provided answers to long standing questions, others have raised even more basic biological questions. There still remains a vast need for understanding many significant pathologies at the genomic level. LC Sciences provides comprehensive services to the academic and biotech communities that are designed to be one-stop and produce the results needed to quickly advance our customers’ biological and biomedical research.
Development of novel clinical diagnostics and molecular medicines is key to fulfilling the promise of personalized medicine for treating cancer, heart disease, neurological disorders and other significant diseases. The identification of novel biomarkers based on disease-related genes, genetic mutations, and known genomes of infectious viruses and pathogens will require integrated technology platforms such as those developed at LC Sciences.
The study of key traits such as plant growth and development, stress response, hybrid vigor, and reproduction at the genomic level will be essential for agronomic advancement. Though new focus on agriculture has provided a large amount of new genomic information and tools, there still remains a challenge of working with non-model, highly varied species. LC Sciences’ innovative products and comprehensive services are based on in-house developed parallel-synthesis and targeted sequencing technologies that offer unprecedented flexibility and customization capability.
Our Latests Successes
- New Study Uncovers Information Regarding the Complex Mechanisms Underlying Mitochondrial Myopathy
- MiR-598 Implicated as Novel Regulator of Colorectal Cancer Metastasis
- Researchers Uncover the Origin of Plant miRNAs and the Mechanism of Salicaceae Gene Evolution
- Researchers Use Molecular Inversion Probes to Study a Unique Form of Leukoencephalopathy
- Novel Age-Based Circulating miRNA Signature Predicts Development of Lymphoma
- New Evidence Suggests Down-Regulation of miRNA-1 Can Protect the Heart from Ischemia–Reperfusion Injury
- Evidence Suggests Cell Proliferation-Associated miRNA Expression Induced by Electroacupuncture is Associated with Improved Cerebral Blood Supply